On a molecular basis, alterations affecting the RAS/RAF/MAPK signaling cascade - such as KRAS, NRAS, BRAF, and others - are commonly reported in histiocytic sarcoma [1,5]. This evidence concerns the gene BRAF and histiocytic sarcoma.